Prediction of the clinical chemotherapeutic response of stage III lung adenocarcinoma patients by an in vitro short term test.
作者信息
Volm M, Drings P, Hahn E W, Mattern J
机构信息
German Cancer Research Center, Institute of Experimental Pathology, Heidelberg, Germany.
出版信息
Br J Cancer. 1988 Feb;57(2):198-200. doi: 10.1038/bjc.1988.42.
Abstract
摘要
相似文献
1
Prediction of the clinical chemotherapeutic response of stage III lung adenocarcinoma patients by an in vitro short term test.通过体外短期试验预测Ⅲ期肺腺癌患者的临床化疗反应
Br J Cancer. 1988 Feb;57(2):198-200. doi: 10.1038/bjc.1988.42.
2
[Adenocarcinoma].
Nihon Rinsho. 2000 May;58(5):1117-20.
3
A phase I study of nedaplatin, pemetrexed and thoracic intensity-modulated radiotherapy for inoperable stage III lung adenocarcinoma.奈达铂、培美曲塞与胸部调强放疗用于不可切除的Ⅲ期肺腺癌的Ⅰ期研究。
BMC Cancer. 2016 Oct 7;16(1):775. doi: 10.1186/s12885-016-2800-5.
4
[Concurrent chemoradiotherapy using a single agent for unresectable stage III non-small cell lung cancer].[使用单一药物对不可切除的III期非小细胞肺癌进行同步放化疗]
Gan To Kagaku Ryoho. 2000 Oct;27(11):1755-8.
5
Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer.紫杉醇联合顺铂新辅助化疗治疗 III 期 N2 非小细胞肺癌。
Clin Lung Cancer. 2013 Jul;14(4):418-24. doi: 10.1016/j.cllc.2012.10.003. Epub 2013 Jan 4.
6
[Bronchial arterial infusion chemotherapy with or without radiotherapy for advanced lung cancer].[支气管动脉灌注化疗联合或不联合放疗治疗晚期肺癌]
Zhonghua Zhong Liu Za Zhi. 1990 May;12(3):216-8.
7
[Long-term results of surgical plus chemotherapy for stage I lung adenocarcinoma].
Zhonghua Yi Xue Za Zhi. 2009 Jun 16;89(23):1630-2.
8
Cisplatin plus epirubicin and etoposide followed by irradiation plus lonidamine in stage III nonsmall cell lung cancer.顺铂联合表柔比星和依托泊苷治疗后行放疗加氯尼达明治疗Ⅲ期非小细胞肺癌
Oncology. 1993;50(1):10-3. doi: 10.1159/000227139.
9
A lung cancer responding to hormonal therapy.
J Thorac Oncol. 2010 May;5(5):749-50. doi: 10.1097/JTO.0b013e3181d1271d.
10
[Therapy for lung cancer in view of internal medicine].
Kokyu To Junkan. 1993 Sep;41(9):815-24.
引用本文的文献
1
Prediction of Cancer Drug Resistance and Implications for Personalized Medicine.癌症耐药性的预测及其对个性化医疗的意义。
Front Oncol. 2015 Dec 17;5:282. doi: 10.3389/fonc.2015.00282. eCollection 2015.
2
Protein expression profiles indicative for drug resistance of non-small cell lung cancer.非小细胞肺癌耐药性的蛋白质表达谱
Br J Cancer. 2002 Jul 29;87(3):251-7. doi: 10.1038/sj.bjc.6600463.
3
Induced multidrug resistance in murine leukemia L1210 and associated changes in a surface-membrane glycoprotein.小鼠白血病L1210中的诱导多药耐药性及表面膜糖蛋白的相关变化。
J Cancer Res Clin Oncol. 1989;115(1):17-24. doi: 10.1007/BF00391594.
4
DNA analysis, chemoresistance testing and hormone receptor levels as prognostic factors in advanced ovarian carcinoma.DNA分析、化疗耐药性检测及激素受体水平作为晚期卵巢癌的预后因素
Arch Gynecol Obstet. 1990;248(1):45-52. doi: 10.1007/BF02389589.
5
Relationship between chemoresistance of lung tumours and cigarette smoking.肺肿瘤的化疗耐药性与吸烟之间的关系。
Br J Cancer. 1990 Aug;62(2):255-6. doi: 10.1038/bjc.1990.271.
6
Prediction of response to drug therapy of cancer. A review of in vitro assays.癌症药物治疗反应的预测。体外试验综述。
Drugs. 1992 Nov;44(5):690-708. doi: 10.2165/00003495-199244050-00002.
本文引用的文献
1
A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.一种用于比较任意单删失样本的广义威尔科克森检验。
Biometrika. 1965 Jun;52:203-23.
2
Clinical relevance of predictive tests for cancer chemotherapy.癌症化疗预测性检测的临床相关性。
Cancer Treat Rev. 1982 Dec;9(4):267-98. doi: 10.1016/s0305-7372(82)80041-8.
3
Use of tritiated nucleotide incorporation for prediction of sensitivity of tumors to cytostatic agents.利用氚标记核苷酸掺入法预测肿瘤对细胞生长抑制剂的敏感性。
Behring Inst Mitt. 1984 May(74):273-84.
4
Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy.肿瘤耐药性的治疗前检测及肿瘤化疗结果
Eur J Cancer (1965). 1979 Jul;15(7):983-93. doi: 10.1016/0014-2964(79)90282-2.
5
Adjuvant chemotherapy in lung cancer: review and prospects.
Cancer. 1977 Apr;39(4):1415-24. doi: 10.1002/1097-0142(197704)39:4<1415::aid-cncr2820390410>3.0.co;2-o.
6
Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.人类肿瘤干细胞对抗癌药物的差异敏感性定量分析。
N Engl J Med. 1978 Jun 15;298(24):1321-7. doi: 10.1056/NEJM197806152982401.
7
Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity.
J Cell Physiol. 1976 May;88(1):23-31. doi: 10.1002/jcp.1040880104.
Zotero 插件